Landmark Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Methodology to the agency and the finding -- >> that's a clear violation of rules protecting patient confidentiality. who is protecting the subjects in those studies. you have promised us a replacement rule for the clean power plant. would that acknowledge the health impacts of fine particle pollution? >> we have been, as you know, proposed rural marketplace on just that issue. >> i mentioned the risks of lead in drinking water. so with this new rule, those risks were shown by epidemiological studies that protected the patient confidentiality and all the other things of confidential informatio...

City study which proved a connection between air pollution and early death back in 1993. that just by living in a city with poor air quality your average life expectancy was lower than those who did it. this study later became the basis of fine matter regulations in the clear air act. when you were here in december, we spoke about fine particle matter which thanks to studies based on confidential patient health information we now know is associated with premature death, asthma attacks, decreased lung function and respiratory diseases. you acknowledged these risks and agree there is no safe lev...

The support for the regulation, is that not correct? >> it is. what has been of note to me, as i've been certain at the agency, there are reliance, a reliance at the agency on many third party studies. as the studies are supportive of rule-making, important to make sure the methodology and data accompany the conclusions so the american people can make informed decision about the rules and whether they actually are based on sound science. >> this is to get a little bit to the budget, we're actually here to discuss, there is a program in your agency called leaking underground storage tanks. shor...

Bypassing or the ppo process not being respected. >> i'm concerned that you have no idea of what is going on in your name at your agency, especially on an issue already under ig investigation. you spent this week claiming to champion transparency, but on tuesday, you blocked the press from attending an event where you announced a new proposal that will severely limit the agency's use of public health studies and policymaking. when internal e-mails came out about this new policy, they  revealed that it had been developed entirely by political staff, without a robust outside stake holder proces...

Transparency. i've had a lot of constituents over the years been very concerned about decisions and various agencies that get made by administrators or the bureaucracy and in some cases they can't get access to the underlying data that underpins the decisions. the proposal you put forward, how does that address that issue? will it be replicated, maybe peer reviewed, so that we can all work off facts? >> this is -- this is an interest to congress. there is proposed legislation to address this very issue. this was a regulatory action taken this week, proposed rule, that actually goes to the hear...